Department of Internal Medicine, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Nepalese Army Institute of Health Sciences, Syanobharyang, Kathmandu, Nepal.
JNMA J Nepal Med Assoc. 2022 May 5;60(249):448-452. doi: 10.31729/jnma.7258.
Chronic kidney disease is defined as structural or functional damage of the kidney persisting for three or more months. Studies have shown hypertension and diabetes as the leading causes of chronic kidney disease. The aim of this study is to find out the prevalence of end-stage renal disease patients undergoing haemodialysis in a tertiary care hospital.
This was a descriptive cross-sectional study conducted among 96 patients undergoing haemodialysis from February 13, 2021 to April 4, 2021 in the hemodialysis unit of a tertiary care centre after receiving ethical clearance from the Institutional Review Committee (Reference number: 354). Convenience sampling was done and all patients older than 18 years who were on maintenance haemodialysis on an outpatient basis were included in the study. Data were collected using a self-administered questionnaire. Data were analysed using the Statistical Package for the Social Science version 22.0. Point estimate at 95% Confidence Interval was calculated along with frequency and percentages for binary data and mean with standard deviation for continuous data.
Among 96 patients undergoing haemodialysis, the prevalence of end-stage renal disease was 83 (86.45%) (79.60-93.30 at 95% Confidence Interval). The most common underlying condition was hypertensive nephropathy in 34 (40.96%) patients, followed by both hypertensive and diabetic nephropathy in 26 (31.33%) patients.
The prevalence of end-stage renal disease in our study was higher when compared to similar studies conducted in similar settings. Early diagnosis and adequate treatment of hypertension and diabetes could be crucial to reducing the prevalence of the end-stage renal disease.
chronic kidney failure; chronic renal insufficiency; end stage renal disease; hemodialysis; Nepal.
慢性肾脏病定义为肾脏结构或功能损伤持续三个月或以上。研究表明,高血压和糖尿病是慢性肾脏病的主要病因。本研究旨在了解三级保健医院行血液透析的终末期肾病患者的患病率。
这是一项在获得机构审查委员会的伦理批准(参考编号:354)后,于 2021 年 2 月 13 日至 2021 年 4 月 4 日在三级保健中心血液透析单位进行的描述性横断面研究。采用便利抽样法,纳入所有年龄大于 18 岁、在门诊行维持性血液透析的患者。使用自填式问卷收集数据。使用社会科学统计软件包 22.0 版分析数据。计算了 95%置信区间的点估计值,以及二分类数据的频率和百分比和连续数据的均值和标准差。
在 96 例行血液透析的患者中,终末期肾病的患病率为 83 例(86.45%)(95%置信区间为 79.60-93.30)。最常见的基础疾病是 34 例(40.96%)高血压性肾病,其次是高血压和糖尿病性肾病 26 例(31.33%)。
与类似环境下进行的类似研究相比,本研究中终末期肾病的患病率更高。早期诊断和充分治疗高血压和糖尿病可能对降低终末期肾病的患病率至关重要。
慢性肾衰竭;慢性肾功能不全;终末期肾病;血液透析;尼泊尔。